Envoy Medical (COCHW) Cash & Equivalents (2021 - 2026)

Envoy Medical's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $25.3 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 375.36% year-over-year to $25.3 million; the TTM figure through Mar 2026 stood at $25.3 million (up 375.36% YoY), while the FY2025 annual figure was $3.7 million, down 31.81% from the prior year.
• Cash & Equivalents came in at $25.3 million for Q1 2026 at Envoy Medical, up from $3.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $25.3 million in Q1 2026 to a low of $68000.0 in Q2 2023.
• A 5-year average of $5.2 million and a median of $4.0 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents sank 94.1% in 2022 and jumped 5476.21% in 2023, its largest moves.
• Envoy Medical's Cash & Equivalents stood at $183000.0 in 2022, then soared by 2205.46% to $4.2 million in 2023, then increased by 29.96% to $5.5 million in 2024, then plunged by 31.81% to $3.7 million in 2025, then jumped by 575.34% to $25.3 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $25.3 million, $3.7 million, and $3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison